Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 3
1916 1
1956 2
1957 1
1961 8
1962 5
1963 2
1964 1
1965 1
1966 4
1967 6
1968 4
1969 8
1970 9
1971 4
1972 8
1973 12
1974 9
1975 11
1976 9
1977 9
1978 28
1979 20
1980 17
1981 24
1982 16
1983 20
1984 19
1985 31
1986 37
1987 35
1988 35
1989 37
1990 33
1991 32
1992 54
1993 43
1994 44
1995 37
1996 47
1997 39
1998 49
1999 43
2000 58
2001 47
2002 40
2003 46
2004 45
2005 51
2006 46
2007 53
2008 55
2009 45
2010 37
2011 42
2012 60
2013 48
2014 56
2015 65
2016 52
2017 79
2018 82
2019 77
2020 99
2021 107
2022 126
2023 107
2024 96
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,259 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, Lee KW, Omori T, Shitara K, Sakuramoto S, Chung IJ, Yamaguchi K, Kato K, Sym SJ, Kadowaki S, Tsuji K, Chen JS, Bai LY, Oh SY, Choda Y, Yasui H, Takeuchi K, Hirashima Y, Hagihara S, Boku N. Kang YK, et al. Among authors: tsuji k. Lancet Oncol. 2022 Feb;23(2):234-247. doi: 10.1016/S1470-2045(21)00692-6. Epub 2022 Jan 11. Lancet Oncol. 2022. PMID: 35030335 Clinical Trial.
MicroRNAs as Biomarkers for Nephrotic Syndrome.
Tsuji K, Kitamura S, Wada J. Tsuji K, et al. Int J Mol Sci. 2020 Dec 23;22(1):88. doi: 10.3390/ijms22010088. Int J Mol Sci. 2020. PMID: 33374848 Free PMC article. Review.
Reply: Letter to the editor.
Tsuji K. Tsuji K. J Orthop Res. 2021 Dec;39(12):2535-2536. doi: 10.1002/jor.25028. Epub 2021 Mar 29. J Orthop Res. 2021. PMID: 33783018 Free article. No abstract available.
Warburg effect in Gynecologic cancers.
Kobayashi Y, Banno K, Kunitomi H, Takahashi T, Takeda T, Nakamura K, Tsuji K, Tominaga E, Aoki D. Kobayashi Y, et al. Among authors: tsuji k. J Obstet Gynaecol Res. 2019 Mar;45(3):542-548. doi: 10.1111/jog.13867. Epub 2018 Dec 3. J Obstet Gynaecol Res. 2019. PMID: 30511455 Review.
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment.
Imaoka H, Ikeda M, Umemoto K, Sunakawa Y, Ueno M, Ueno H, Ozaka M, Kuwahara T, Okano N, Kanai M, Hisano T, Suzuki Y, Asagi A, Shioji K, Todaka A, Tsuji K, Ikezawa K, Miki I, Komatsu Y, Akutsu N, Yamashita T, Okuyama H, Furuse J, Nagano H. Imaoka H, et al. Among authors: tsuji k. Jpn J Clin Oncol. 2023 Aug 30;53(9):764-773. doi: 10.1093/jjco/hyad062. Jpn J Clin Oncol. 2023. PMID: 37325968 Free PMC article. Review.
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Yano S, Kawaoka T, Yamasaki S, Johira Y, Kosaka M, Shirane Y, Miura R, Amioka K, Naruto K, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Ono A, Nakahara T, Murakami E, Miki D, Tsuge M, Teraoka Y, Kouno H, Takaki S, Mori N, Tsuji K, Oka S. Yano S, et al. Among authors: tsuji k. Cancers (Basel). 2023 Nov 14;15(22):5406. doi: 10.3390/cancers15225406. Cancers (Basel). 2023. PMID: 38001666 Free PMC article.
Intraspecific Adaptation Load: A Mechanism for Species Coexistence.
Yamamichi M, Kyogoku D, Iritani R, Kobayashi K, Takahashi Y, Tsurui-Sato K, Yamawo A, Dobata S, Tsuji K, Kondoh M. Yamamichi M, et al. Among authors: tsuji k. Trends Ecol Evol. 2020 Oct;35(10):897-907. doi: 10.1016/j.tree.2020.05.011. Epub 2020 Jul 13. Trends Ecol Evol. 2020. PMID: 32674869 Review.
Effects of HIF-PHD inhibitors in kidney development.
Haraguchi S, Tsuji K, Nakanoh H, Fukushima K, Kitamura S, Wada J. Haraguchi S, et al. Among authors: tsuji k. Nephrol Dial Transplant. 2024 Jul 31;39(8):1368-1370. doi: 10.1093/ndt/gfae078. Nephrol Dial Transplant. 2024. PMID: 38553963 Review. No abstract available.
Recent traction methods for endoscopic submucosal dissection.
Tsuji K, Yoshida N, Nakanishi H, Takemura K, Yamada S, Doyama H. Tsuji K, et al. World J Gastroenterol. 2016 Jul 14;22(26):5917-26. doi: 10.3748/wjg.v22.i26.5917. World J Gastroenterol. 2016. PMID: 27468186 Free PMC article. Review.
2,259 results